| Open Document File Size: 49,95 KBShare Result on Facebook
Company Study 2 / Amgen / / Event FDA Phase / / Facility Laboratory Monitoring / / IndustryTerm food consumption / drug product / treatment of metastatic breast cancer / / MedicalCondition anaphylactic reaction / tumor / bladder tumor / cancer / Carcinogenesis / Respiratory Distress Syndrome / WITH CANCER / myeloid leukemia / neutropenia / skin rash / anaphylaxis / fever / C disease / PAIN / renal insufficiency / metastatic breast cancer / febrile neutropenia / myelodysplasia / urticaria / Allergic Reactions / Sickle Cell Disease / hypersensitivity / infection / thalassemia / Splenic Rupture / inflammation / febrile neutropenia found / specifically homozygous sickle cell anemia / sepsis / severe neutropenia / respiratory distress / serious allergic reaction / / MedicalTreatment Radiation Therapy / chemotherapy / remission induction / / Person Package Insert Neulasta / / Position prescribing physician / Physician / General / / Product Subcutaneous injections / SC / NEUPOGEN / SC injection / sorbitol / Neulasta / fluorouracil / mitomycin / / ProvinceOrState ARDS / / Technology Pharmacokinetics / Radiation / chemotherapy / pharmacodynamics / /
SocialTag |
Label - Pegfilgrastim, ( Neulasta), Amgen Incorporated